Global Glioblastoma Multiforme (GBM) Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pipeline.
The global Glioblastoma Multiforme (GBM) Therapeutics market size is projected to grow from US$ 536.3 million in 2023 to US$ 985.3 million in 2030; it is expected to grow at a CAGR of 9.1% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Glioblastoma Multiforme (GBM) Therapeutics Industry Forecast” looks at past sales and reviews total world Glioblastoma Multiforme (GBM) Therapeutics sales in 2023, providing a comprehensive analysis by region and market sector of projected Glioblastoma Multiforme (GBM) Therapeutics sales for 2024 through 2030. With Glioblastoma Multiforme (GBM) Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glioblastoma Multiforme (GBM) Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Glioblastoma Multiforme (GBM) Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glioblastoma Multiforme (GBM) Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glioblastoma Multiforme (GBM) Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glioblastoma Multiforme (GBM) Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glioblastoma Multiforme (GBM) Therapeutics.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Glioblastoma Multiforme (GBM) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type
Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pipeline.
The global Glioblastoma Multiforme (GBM) Therapeutics market size is projected to grow from US$ 536.3 million in 2023 to US$ 985.3 million in 2030; it is expected to grow at a CAGR of 9.1% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Glioblastoma Multiforme (GBM) Therapeutics Industry Forecast” looks at past sales and reviews total world Glioblastoma Multiforme (GBM) Therapeutics sales in 2023, providing a comprehensive analysis by region and market sector of projected Glioblastoma Multiforme (GBM) Therapeutics sales for 2024 through 2030. With Glioblastoma Multiforme (GBM) Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glioblastoma Multiforme (GBM) Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Glioblastoma Multiforme (GBM) Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glioblastoma Multiforme (GBM) Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glioblastoma Multiforme (GBM) Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glioblastoma Multiforme (GBM) Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glioblastoma Multiforme (GBM) Therapeutics.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Glioblastoma Multiforme (GBM) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type
- ChemOthersapy
- Targeted Drug Therapy
- Radiation Therapy
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Roche
- Arbor Pharmaceuticals
- Pfizer
- AbbVie
- Amgen
- Bristol-Myers Squibb
- Sun Pharmaceuticals
- Teva Pharmaceutical
- Emcure Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size 2019-2030
2.1.2 Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Glioblastoma Multiforme (GBM) Therapeutics Segment by Type
2.2.1 ChemOthersapy
2.2.2 Targeted Drug Therapy
2.2.3 Radiation Therapy
2.3 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type
2.3.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Glioblastoma Multiforme (GBM) Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application
2.5.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
3 GLIOBLASTOMA MULTIFORME (GBM) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Players
3.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Glioblastoma Multiforme (GBM) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GLIOBLASTOMA MULTIFORME (GBM) THERAPEUTICS BY REGIONS
4.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2019-2024)
4.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2019-2024)
4.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Country (2019-2024)
5.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024)
5.3 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Region (2019-2024)
6.2 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024)
6.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Glioblastoma Multiforme (GBM) Therapeutics by Country (2019-2024)
7.2 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024)
7.3 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GLIOBLASTOMA MULTIFORME (GBM) THERAPEUTICS MARKET FORECAST
10.1 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.1.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.1.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.1.5 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.2.2 Canada Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.2.3 Mexico Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.2.4 Brazil Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Forecast by Region (2025-2030)
10.3.1 China Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.2 Japan Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.3 Korea Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.4 Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.5 India Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.6 Australia Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.2 France Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.3 UK Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.4 Italy Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.5 Russia Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.2 South Africa Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.3 Israel Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.4 Turkey Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.5 GCC Countries Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.6 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Type (2025-2030)
10.7 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.1.3 Merck Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.2.3 Roche Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Arbor Pharmaceuticals
11.3.1 Arbor Pharmaceuticals Company Information
11.3.2 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Arbor Pharmaceuticals Main Business Overview
11.3.5 Arbor Pharmaceuticals Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.4.3 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 AbbVie
11.5.1 AbbVie Company Information
11.5.2 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.5.3 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AbbVie Main Business Overview
11.5.5 AbbVie Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.6.3 Amgen Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.7.3 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bristol-Myers Squibb Main Business Overview
11.7.5 Bristol-Myers Squibb Latest Developments
11.8 Sun Pharmaceuticals
11.8.1 Sun Pharmaceuticals Company Information
11.8.2 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.8.3 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sun Pharmaceuticals Main Business Overview
11.8.5 Sun Pharmaceuticals Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.9.3 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
11.10 Emcure Pharmaceuticals
11.10.1 Emcure Pharmaceuticals Company Information
11.10.2 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.10.3 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Emcure Pharmaceuticals Main Business Overview
11.10.5 Emcure Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size 2019-2030
2.1.2 Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Glioblastoma Multiforme (GBM) Therapeutics Segment by Type
2.2.1 ChemOthersapy
2.2.2 Targeted Drug Therapy
2.2.3 Radiation Therapy
2.3 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type
2.3.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Glioblastoma Multiforme (GBM) Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application
2.5.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
3 GLIOBLASTOMA MULTIFORME (GBM) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Players
3.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Glioblastoma Multiforme (GBM) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GLIOBLASTOMA MULTIFORME (GBM) THERAPEUTICS BY REGIONS
4.1 Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2019-2024)
4.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2019-2024)
4.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Country (2019-2024)
5.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024)
5.3 Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Region (2019-2024)
6.2 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024)
6.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Glioblastoma Multiforme (GBM) Therapeutics by Country (2019-2024)
7.2 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024)
7.3 Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GLIOBLASTOMA MULTIFORME (GBM) THERAPEUTICS MARKET FORECAST
10.1 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.1.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.1.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.1.5 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Forecast
10.2 Americas Glioblastoma Multiforme (GBM) Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.2.2 Canada Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.2.3 Mexico Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.2.4 Brazil Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3 APAC Glioblastoma Multiforme (GBM) Therapeutics Forecast by Region (2025-2030)
10.3.1 China Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.2 Japan Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.3 Korea Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.4 Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.5 India Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.3.6 Australia Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4 Europe Glioblastoma Multiforme (GBM) Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.2 France Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.3 UK Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.4 Italy Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.4.5 Russia Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5 Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.2 South Africa Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.3 Israel Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.4 Turkey Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.5.5 GCC Countries Glioblastoma Multiforme (GBM) Therapeutics Market Forecast
10.6 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Type (2025-2030)
10.7 Global Glioblastoma Multiforme (GBM) Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.1.3 Merck Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.2.3 Roche Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Arbor Pharmaceuticals
11.3.1 Arbor Pharmaceuticals Company Information
11.3.2 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Arbor Pharmaceuticals Main Business Overview
11.3.5 Arbor Pharmaceuticals Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.4.3 Pfizer Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 AbbVie
11.5.1 AbbVie Company Information
11.5.2 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.5.3 AbbVie Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AbbVie Main Business Overview
11.5.5 AbbVie Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.6.3 Amgen Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.7.3 Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bristol-Myers Squibb Main Business Overview
11.7.5 Bristol-Myers Squibb Latest Developments
11.8 Sun Pharmaceuticals
11.8.1 Sun Pharmaceuticals Company Information
11.8.2 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.8.3 Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sun Pharmaceuticals Main Business Overview
11.8.5 Sun Pharmaceuticals Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.9.3 Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
11.10 Emcure Pharmaceuticals
11.10.1 Emcure Pharmaceuticals Company Information
11.10.2 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
11.10.3 Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Emcure Pharmaceuticals Main Business Overview
11.10.5 Emcure Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of ChemOthersapy
Table 3. Major Players of Targeted Drug Therapy
Table 4. Major Players of Radiation Therapy
Table 5. Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Glioblastoma Multiforme (GBM) Therapeutics Key Players Head office and Products Offered
Table 14. Glioblastoma Multiforme (GBM) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Regions (2019-2024)
Table 19. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Table 31. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Table 33. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Country (2019-2024)
Table 35. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Table 37. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Glioblastoma Multiforme (GBM) Therapeutics
Table 46. Key Market Challenges & Risks of Glioblastoma Multiforme (GBM) Therapeutics
Table 47. Key Industry Trends of Glioblastoma Multiforme (GBM) Therapeutics
Table 48. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Merck Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 53. Merck Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 54. Merck Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Merck Main Business
Table 56. Merck Latest Developments
Table 57. Roche Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 58. Roche Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 59. Roche Main Business
Table 60. Roche Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Roche Latest Developments
Table 62. Arbor Pharmaceuticals Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 63. Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 64. Arbor Pharmaceuticals Main Business
Table 65. Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Arbor Pharmaceuticals Latest Developments
Table 67. Pfizer Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 68. Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Pfizer Latest Developments
Table 72. AbbVie Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 73. AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 74. AbbVie Main Business
Table 75. AbbVie Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. AbbVie Latest Developments
Table 77. Amgen Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 78. Amgen Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 79. Amgen Main Business
Table 80. Amgen Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Amgen Latest Developments
Table 82. Bristol-Myers Squibb Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 83. Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 84. Bristol-Myers Squibb Main Business
Table 85. Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Bristol-Myers Squibb Latest Developments
Table 87. Sun Pharmaceuticals Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 88. Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 89. Sun Pharmaceuticals Main Business
Table 90. Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Sun Pharmaceuticals Latest Developments
Table 92. Teva Pharmaceutical Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 93. Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 94. Teva Pharmaceutical Main Business
Table 95. Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Teva Pharmaceutical Latest Developments
Table 97. Emcure Pharmaceuticals Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 98. Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 99. Emcure Pharmaceuticals Main Business
Table 100. Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Emcure Pharmaceuticals Latest Developments
Table 1. Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of ChemOthersapy
Table 3. Major Players of Targeted Drug Therapy
Table 4. Major Players of Radiation Therapy
Table 5. Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Glioblastoma Multiforme (GBM) Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Glioblastoma Multiforme (GBM) Therapeutics Key Players Head office and Products Offered
Table 14. Glioblastoma Multiforme (GBM) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Regions (2019-2024)
Table 19. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Table 31. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Table 33. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Country (2019-2024)
Table 35. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Table 37. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Glioblastoma Multiforme (GBM) Therapeutics
Table 46. Key Market Challenges & Risks of Glioblastoma Multiforme (GBM) Therapeutics
Table 47. Key Industry Trends of Glioblastoma Multiforme (GBM) Therapeutics
Table 48. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Merck Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 53. Merck Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 54. Merck Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Merck Main Business
Table 56. Merck Latest Developments
Table 57. Roche Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 58. Roche Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 59. Roche Main Business
Table 60. Roche Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Roche Latest Developments
Table 62. Arbor Pharmaceuticals Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 63. Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 64. Arbor Pharmaceuticals Main Business
Table 65. Arbor Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Arbor Pharmaceuticals Latest Developments
Table 67. Pfizer Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 68. Pfizer Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Pfizer Latest Developments
Table 72. AbbVie Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 73. AbbVie Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 74. AbbVie Main Business
Table 75. AbbVie Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. AbbVie Latest Developments
Table 77. Amgen Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 78. Amgen Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 79. Amgen Main Business
Table 80. Amgen Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Amgen Latest Developments
Table 82. Bristol-Myers Squibb Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 83. Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 84. Bristol-Myers Squibb Main Business
Table 85. Bristol-Myers Squibb Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Bristol-Myers Squibb Latest Developments
Table 87. Sun Pharmaceuticals Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 88. Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 89. Sun Pharmaceuticals Main Business
Table 90. Sun Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Sun Pharmaceuticals Latest Developments
Table 92. Teva Pharmaceutical Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 93. Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 94. Teva Pharmaceutical Main Business
Table 95. Teva Pharmaceutical Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Teva Pharmaceutical Latest Developments
Table 97. Emcure Pharmaceuticals Details, Company Type, Glioblastoma Multiforme (GBM) Therapeutics Area Served and Its Competitors
Table 98. Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Product Offered
Table 99. Emcure Pharmaceuticals Main Business
Table 100. Emcure Pharmaceuticals Glioblastoma Multiforme (GBM) Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Emcure Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Glioblastoma Multiforme (GBM) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Glioblastoma Multiforme (GBM) Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Glioblastoma Multiforme (GBM) Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Glioblastoma Multiforme (GBM) Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type in 2023
Figure 10. Glioblastoma Multiforme (GBM) Therapeutics in Hospitals
Figure 11. Global Glioblastoma Multiforme (GBM) Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Glioblastoma Multiforme (GBM) Therapeutics in Clinics
Figure 13. Global Glioblastoma Multiforme (GBM) Therapeutics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Glioblastoma Multiforme (GBM) Therapeutics in Others
Figure 15. Global Glioblastoma Multiforme (GBM) Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Glioblastoma Multiforme (GBM) Therapeutics Value Market Share by Country in 2023
Figure 24. United States Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Glioblastoma Multiforme (GBM) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Glioblastoma Multiforme (GBM) Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Glioblastoma Multiforme (GBM) Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Glioblastoma Multiforme (GBM) Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type in 2023
Figure 10. Glioblastoma Multiforme (GBM) Therapeutics in Hospitals
Figure 11. Global Glioblastoma Multiforme (GBM) Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Glioblastoma Multiforme (GBM) Therapeutics in Clinics
Figure 13. Global Glioblastoma Multiforme (GBM) Therapeutics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Glioblastoma Multiforme (GBM) Therapeutics in Others
Figure 15. Global Glioblastoma Multiforme (GBM) Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Glioblastoma Multiforme (GBM) Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Glioblastoma Multiforme (GBM) Therapeutics Value Market Share by Country in 2023
Figure 24. United States Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Glioblastoma Multiforme (GBM) Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Glioblastoma Multiforme (GBM) Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Glioblastoma Multiforme (GBM) Therapeutics Market Size Market Share Forecast by Application (2025-2030)
